Small ligands modulating the activity of mammalian adenylyl cyclases: A novel mode of inhibition by calmidazolium

Molecular Pharmacology

Volumn 63, Issue 3, 2003, Pages 624-631

  Haunsø, Anders ^a   Simpson, James ^a   Antoni, Ferenc A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXYADENOSINE 3' PHOSPHATE; ADENYLATE CYCLASE; ADENYLATE CYCLASE II; ADENYLATE CYCLASE IX; ADENYLATE CYCLASE V; CALMIDAZOLIUM; FUNGICIDE; HYBRID PROTEIN; ISOPROTEIN; LIGAND; NITROIMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG; ZALDARIDE MALEATE;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL; IC 50; MAMMAL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ADENYLATE CYCLASE; ANIMALS; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; KINETICS; LIGANDS; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0037334541     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.3.624     Document Type: Article

References (42)

1. Antoni FA (2000) Molecular diversity of cyclic AMP signalling. Front Neuroendocrinol 21:103-132.
2. Antoni FA, Barnard RJ, Shipston MJ, Smith SM, Simpson J, and Paterson JM (1995) Calcineurin feedback inhibition of agonist-evoked cAMP formation. J Biol Chem 270:28055-28061.
3. 2+/calcineurin-inhibited adenylyl cyclase, highly abundant in forebrain regions, is important for learning and memory. J Neurosci 18:9650-9661.
4. Chang C, Kuo S, Lin Y, Wang J, and Huang L (2001) Benzyloxybenzaldehyde analogues as novel adenylyl cyclase activators. Bioorg Med Chem Lett 11:1971-1974.
5. Chern Y (2000) Regulation of adenylyl cyclase in the central nervous system. Cell Signal 12:195-204.
6. 2+)-ATPase from rabbit kidney proximal tubules. J Biol Chem 266:10249-10253.
7. 2+/calmodulin. Biochem J 278:903-904.
8. Cui H and Green RD (2001) Cell-specific properties of type V and type IX adenylyl cyclase isozymes in 293T cells and embryonic chick ventricular myocytes. Biochem Biophys Res Commun 283:107-112.
9. Desaubry L, Shoshani I, and Johnson RA (1996) Inhibition of adenylyl cyclase by a family of newly synthesized adenine nucleoside 3′-polyphosphates. J Biol Chem 271:14028-14034.
10. Dessauer CW and Gilman AG (1997) The catalytic mechanism of mammalian adenylyl cyclase. Equilibrium binding and kinetic analysis of P-site inhibition. J Biol Chem 272:27787-27795.
11. Dessauer CW, Tesmer JJ, Sprang SR, and Gilman AG (1999) The interactions of adenylate cyclases with P-site inhibitors. Trends Pharmacol Sci 20:205-210.
12. Gu C, Sorkin A, and Cooper DM (2001) Persistent interactions between the two transmembrane clusters dictate the targeting and functional assembly of adenylyl cyclase. Curr Biol 11:185-190.
13. Hanoune J and Defer N (2001) Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41:145-174.
14. Harper JL and Daly JW (2000) Effect of calmidazolium analogs on calcium influx in HL-60 cells. Biochem Pharmacol 60:317-324.
15. Harley JH (1999) Structure, mechanism and regulation of mammalian adenylyl cyclase. J Biol Chem 274:7599-7602.
16. Johnson RA, Desaubry L, Bianchi G, Shoshani I, Lyons E Jr, Taussig R, Watson PA, Cali JJ, Krupinski J, Pieroni JP, et al. (1997) Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3′-polyphosphates. J Biol Chem 272:8962-8966.
17. Johnson RA and Shoshani I (1990) Kinetics of "P"-site-mediated inhibition of adenylyl cyclase and the requirements for substrate. J Biol Chem 265:11595-11600.
18. Kerwin JF Jr (1994) Adenylate cyclase subtypes as molecular drug targets. Annu Rep Med Chem 29:287-296.
19. Klein C, Sunahara RK, Hudson TY, Heyduk T, and Howlett AC (2002) Zinc inhibition of cAMP signaling, J Biol Chem 277:11859-11865.
20. Kudlacek O, Mitterauer T, Nanoff C, Hohenegger M, Tang WJ, Freissmuth M, and Kleuss C (2001) Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet. J Biol Chem 276:3010-3016.
21. Mons N, Harry A, Dubourg P, Premont RT, Iyengar R, and Cooper DM (1995) Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentration at synapses. Proc NatlAcad Sci USA 92:8473-8477.
22. Onda T, Hashimoto Y, Nagai M, Kuramochi H, Saito S, Yamazaki H, Toya Y, Sakai I, Homcy CJ, Nishikawa K, et al (2001) Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms. J Biol Chem 276:47785-47793.
23. Patel TB, Du Z, Pierre S, Cartin L, and Scholich K (2001) Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 269:13-25.
24. Paterson JM, Simpson J, and Antoni FA Dephosphorylation of the C1b segment of adenylyl cyclase type 9 by calcineurin. Biochem Soc Trans 24:583S, 1996.
25. Premont RT, Matsuoka I, Mattei MG, Pouille Y, Defer N, and Hanoune J (1996) Identification and characterization of a widely expressed form of adenylyl cyclase. J Biol Chem 271:13900-13907.
26. Scholich K, Barbier AJ, Mullenix JB, and Patel TB (1997) Characterization of soluble forms of nonchimeric type V adenylyl cyclases. Proc Natl Acad Sci USA 94:2915-2920.
27. Shoshani I, Bianchi G, Desaubry L, Dessauer CW, and Johnson RA (2000) Lys-Ala mutations of type I adenylyl cyclase result in altered susceptibility to inhibition by adenine nucleoside 3′-polyphosphates. Arch Biochem Biophys 374:389-394.
28. Shoshani I, Laux WH, Perigaud C, Gosselin G, and Johnson RA (1999) Inhibition of adenylyl cyclase by acyclic nucleoside phosphonate antiviral agents. J Biol Chem 274:34742-34744.
29. Simpson J and Antoni FA (2001) Isotype selective pharmacology of mammalian adenylyl cyclase. Abstracts of the 11th International Conference on Second Messengers and Phosphoproteins; 2001 April 22-26; Melbourne, Australia. pp 6-50.
30. Stalla GK, Stalla J, K. von Werder, Muller OA, Gerzer R, Hollt V, and Jakobs KH (1989) Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme. Endocrinology 125:699-706.
31. Tang WJ and Gilman AG (1995) Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin. Science (Wash DC) 268:1769-1772.
32. Tang WJ and Hurley JH (1998) Catalytic mechanism and regulation of mammalian adenylyl cyclases. Mol Pharmacol 54:231-240.
33. Tang WJ, Stanzel M, and Gilman AG (1995) Truncation and alanine-scanning mutants of type I adenylyl cyclase. Biochemistry 34:14563-14572.
34. Taussig R and Gilman AG (1995) Mammalian membrane-bound adenylyl cyclases. J Biol Chem 270:1-4.
35. Tesmer JJ, Dessauer CW, Sunahara RK, Murray LD, Johnson RA, Gilman AG, and Sprang SR (2000) Molecular basis for P-site inhibition of adenylyl cyclase. Biochemistry 39:14464-14471.
36. Tesmer JJ, Sunahara RK, Gilman AG, and Sprang SR (1997) Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsα. GTPγS. Science (Wash DC) 278:1907-1916.
37. Van Belle H (1984) The effect of drugs on calmodulin and its interaction with phosphodiesterase. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:557-567.
38. Watson PA (1990) Direct stimulation of adenylate cyclase by mechanical forces in S49 mouse lymphoma cells during hyposmotic swelling. J Biol Chem 265:6569-6575.
39. Whisnant RE, Gilman AG, and Dessauer CW (1996) Interaction of the two cytosolic domains of mammalian adenylyl cyclase. Proc Natl Acad Sci USA 93:6621-6625.
40. Wu Z, Wong ST, and Storms DR (1993) Modification of the calcium and calmodulin sensitivity of the type I adenylyl cyclase by mutagenesis of its calmodulin binding domain. J Biol Chem 268:23766-23768.
41. Yan SZ, Huang ZH, Andrews RK, and Tang WJ (1998) Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase. Mol Pharmacol 53:182-187.
42. Zhang G, Liu Y, Ruoho AE, and Hurley JH (1997) Structure of the adenylyl cyclase catalytic core. Nature (Lond) 386:247-253.